Compare MDU & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDU | TNGX |
|---|---|---|
| Founded | 1924 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.5B |
| IPO Year | 1994 | 2020 |
| Metric | MDU | TNGX |
|---|---|---|
| Price | $20.55 | $27.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $21.67 | ★ $21.78 |
| AVG Volume (30 Days) | 1.4M | ★ 2.0M |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.55% | N/A |
| EPS Growth | N/A | ★ 26.89 |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $1,875,066,000.00 | $62,384,000.00 |
| Revenue This Year | $7.52 | N/A |
| Revenue Next Year | $6.00 | N/A |
| P/E Ratio | $53.23 | ★ N/A |
| Revenue Growth | 6.66 | ★ 48.29 |
| 52 Week Low | $15.76 | $6.25 |
| 52 Week High | $22.98 | $34.39 |
| Indicator | MDU | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 50.90 | 53.56 |
| Support Level | $20.06 | $27.79 |
| Resistance Level | $21.32 | $33.96 |
| Average True Range (ATR) | 0.49 | 1.59 |
| MACD | -0.03 | 0.11 |
| Stochastic Oscillator | 66.12 | 74.59 |
MDU Resources Group Inc is a pure-play regulated energy delivery business. It is organized into three reportable business segments: Electric, Natural Gas Distribution, and Pipeline. Maximum revenue is generated from the Pipeline segment, which provides natural gas transportation and underground storage services through a FERC-regulated pipeline system mainly in the Rocky Mountain and northern Great Plains regions of the United States. This segment also provides non-regulated energy-related services, including cathodic protection. The electric segment generates, transmits, and distributes electricity in Montana, North Dakota, South Dakota, and Wyoming, and the natural gas distribution segment distributes natural gas in those states, as well as in Idaho, Minnesota, Oregon, and Washington.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.